Concerta vs Vyvanse: Key Differences in Efficacy and Side Effects

Mechanism and Pharmacology

The American Academy of Child and Adolescent Psychiatry suggests that Vyvanse is a prodrug that must be converted to dextroamphetamine after ingestion, while Concerta uses an osmotic-release system (OROS) to deliver methylphenidate throughout the day 3
Vyvanse's prodrug design makes extraction of the active stimulant component more difficult, conferring lower abuse potential—particularly important in adolescents 3
Concerta's OROS technology produces an ascending plasma drug level pattern designed to last 12 hours, equivalent to methylphenidate given three times daily 2

The American Academy of Child and Adolescent Psychiatry reports that both medications demonstrate robust efficacy across multiple domains of ADHD symptoms with no clinically meaningful differences in overall effectiveness 1, 2
Short-term trials (typically 3 months or less) show approximately 70% response rates for stimulants as a class 2

The American Academy of Child and Adolescent Psychiatry states that the side effect profiles are essentially identical between the two medications, as both are CNS stimulants affecting similar neurotransmitter systems 1
Appetite suppression can be managed by giving medication with meals and offering high-calorie snacks in the evening when effects wear off 1
Insomnia can be addressed by distinguishing whether it is due to medication side effect versus oppositional behavior; lowering the dose or moving it earlier in the day 1
Weight loss is associated with small weight decrements during short-term trials, but long-term follow-up shows no significant impairment of final height attained 1

The American Academy of Pediatrics suggests that Vyvanse may be preferred in adolescents specifically due to lower abuse potential 3
Both medications are DEX Schedule II controlled substances, but Vyvanse's pharmacokinetic properties make extraction and misuse more difficult 3
Oral administration of therapeutic doses has limited ability to induce euphoria compared to other routes 1

Neither medication appears associated with major congenital malformations 3, 4
Possible small increased risks for gastroschisis, preeclampsia, and preterm birth apply to both amphetamines and methylphenidate 3, 4
Both are compatible with breastfeeding with appropriate infant monitoring for irritability, insomnia, and feeding difficulties 4